Stockreport

BioCorRx Pharmaceuticals Inc. Awarded NIDA Grant of Approximately $11 million Over Three Years for Research on BICX104, a Naltrexone Implant in Combination with Bupropion for the Treatment...

BIOCORRX INC NEW  (BICX) 
NASDAQ:AMEX Investor Relations: ir.biocorrx.com
PDF treatment programs for substance use and related disorders, announced that its subsidiary BioCorRx Pharmaceuticals Inc. has been awarded a 3-year grant for approximately [Read more]